1. IDDF2019-ABS-0210 Preliminary efficacy and safety of 8-week glecaprevir/pibrentasvir in patients with HCV genotype 1–6 infection and compensated cirrhosis: the EXPEDITION-8 study. (June 2019) Authors: Brown, Robert S; Hezode, Christopher; Wang, Stanley; Buti, Maria; Chuang, Wan-Long; Aguilar, Humberto; Horvath, Gabor; Carrion, Barbara Rosado; Rodriguez-Perez, Federico; Cohen, Eric; Hu, Yiran B; Schnell, Gretja; Lin, Chih-Wei; Rodrigues, Lino; Trinh, Roger; Mensa, Federico J Journal: Gut Issue: Volume 68(2019)Supplement 1 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗